Aptamers Market cover

Aptamers Market by Types (Peptide and Nucleic Acid), Applications (Diagnostics, Therapeutics, Research & Development, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021-2028

  • Report ID: CG-2272
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 3
  • No. Of Pages: 194
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global aptamers market size is projected to register a substantial CAGR during the forecast period, 2021-2028 attributed to a low chance to provoke immune responses that are undesired, stability even at high thermal, and cost-efficient. A large number of companies are constantly investing in the market as the functional mechanism of aptamers molecule is quite similar to antibodies.

Aptamers Market summary

Short and single-stranded molecules inclusive of DNA or RNA are able to bind to a distinct target selectively that includes small molecules, proteins, carbohydrates, toxins, and peptides. Aptamers are of different shapes as they have a tendency to form helices. They have high selectivity and specificity. Globally, aptamers are extensively studied and examined by the scientists as they provide several advantages such as precise testing for in-vivo procedures and totally enhancing the in-vitro testing method. It also eradicates the time needed for benchmark testing and 35% of the cost along with the time needed in research & development for the production of such molecules. As per the reports published by the Multidisciplinary Digital Publishing Institute (MDPI AG), there is a growth in the research articles on these molecules as in 1995 only 200 research articles were present whereas now nearly more than 1800 research articles are presently published by several companies on the aptamers therapeutics or inspections. Companies including Aptamer Sciences, Inc.; Aptagen, LLC; Aptamer Group; and Optech Biotech gained a momentous presence in the market to increase their influence and capture more untapped market.

The outbreak of COVID-19 pandemic led to the urgent need for rapid method for detection of infectious diseases and the drug & vaccine designs related to SARS-CoV-2. Several types of research show that aptamers are effective for the development of the diagnosis and therapeutics of such diseases that are affordable and effective. Studies also show that aptamers are potential candidates to develop coronavirus therapeutics and are low in cost, user-friendly, sensitive, and can be fabricated rapidly for clinical samples of small volume.

Market Trends, Drivers, Restraints, and Opportunities

  • Development and advancement of technology in the field of aptamers is a major factor to boost the market.
  • Increase in investments made for research and development in research institutes and companies are other driving factors of the market.
  • Favorable supports from government bodies across regions to develop highly effective procedures and increase in awareness are expected to propel the growth of the market.
  • Lack of guidelines for the proper regulation of molecule development is a key restraining factor and is expected to hinder the overall growth of the market.

Scope of the Report

The report on the global infectious disease therapeutics market includes an assessment of the market, trends, and segments. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Aptamers Market – Global Industry Analysis, Growth, Share, Size, Trends, And Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Types (Peptide and Nucleic Acid) and Applications (Diagnostics, Therapeutics, Research & Development, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Eli Lilly & Co.; Aptamer Group; Merck & Co., Inc.; Aptamer Sciences, Inc.; Ophthotech Corp.; Base Pair Biotechnologies, Inc.; SomaLogic, Inc.; and NOXXON Pharma

Market Segment Insights

Nucleic acid segment is expected to dominate the market

On the basis of types, the aptamers market is bifurcated into peptide and nucleic acid. The nucleic acid segment dominated the market by holding over 75.6% share of the overall market revenue and the trend is expected to continue during the forecast period attributed to better chemical and thermal stability of nucleic acid as compared to peptides. Moreover, research & development of nucleic acid is continuously increasing for the betterment of therapeutics. Nucleic acid-based aptamers are being investigated by several companies such as NOXXON Pharma and Ophthotech Corporation for several other purposes. For instance, a nucleic acid aptamer that is chemically synthesized named Fovista developed by Ophthotech Corporation is under clinical investigation. The drug has shown effective and safe results in the 2b phase of clinical studies. On the other hand, the peptide segment is expected to exhibit a moderate revenue share in the coming years due to expansion of the R&D activities on peptides.

Aptamers Market types

Therapeutics segment is anticipated to exhibit a rapid growth rate

Based on applications, the market is segmented into diagnostics, therapeutics, research & development, and others. The diagnostics segment held a major share of the market in 2019 and is projected to register a high CAGR during the projected period owing to molecular imaging, biomarker discovery, and other diagnostics purposes. Moreover, several chronic diseases can also be diagnosed using this molecule and the DNA or RNA aptamers are used for the effective diagnosis of parasitic diseases. However, the therapeutics segment is anticipated to exhibit a rapid growth rate in the coming years attributed to its advantages over antibody drugs as they provide better stability by binding 1,000 times stronger. Additionally, several companies are researching for aptamers for the treatment of chronic diseases including cancers, cardiovascular, neurodegenerative, and HIV.

Asia Pacific market is estimated to expand at a robust growth rate

In terms of regions, the aptamers market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a major market share by representing a high revenue share in 2019 owing to continuous advancement in technology and rise in the number of research institutes for research & development. Meanwhile, the Europe market is anticipated to grow at a fast pace during the forecast period owing to emerging of aptamers technology and their acceptance. Moreover, increase in demand for therapies that are aptamers based and a rise in the prevalence of chronic diseases in the region present another key drivers of the regional market. However, the market of Asia Pacific is estimated to expand at a robust growth rate in the coming years owing to rise in prevalence of chronic diseases and increasing demand for therapies that are cost-effective in the region.

Aptamers Market region

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Aptamers Market Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Aptamers Market Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Aptamers Market Market - Supply Chain
  4.5. Global Aptamers Market Market Forecast
     4.5.1. Aptamers Market Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Aptamers Market Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Aptamers Market Market Absolute $ Opportunity
5. Global Aptamers Market Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Aptamers Market Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Aptamers Market Demand Share Forecast, 2019-2026
6. North America Aptamers Market Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Aptamers Market Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Aptamers Market Demand Share Forecast, 2019-2026
7. Latin America Aptamers Market Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Aptamers Market Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Aptamers Market Demand Share Forecast, 2019-2026
8. Europe Aptamers Market Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Aptamers Market Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Aptamers Market Demand Share Forecast, 2019-2026
9. Asia Pacific Aptamers Market Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Aptamers Market Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Aptamers Market Demand Share Forecast, 2019-2026
10. Middle East & Africa Aptamers Market Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Aptamers Market Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Aptamers Market Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Aptamers Market Market: Market Share Analysis
  11.2. Aptamers Market Distributors and Customers
  11.3. Aptamers Market Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Eli Lilly & Co.
     11.4.2. Aptamer Group
     11.4.3. Merck & Co., Inc.
     11.4.4. Aptamer Sciences, Inc.
     11.4.5. Ophthotech Corp.
     11.4.6. Base Pair Biotechnologies, Inc.
     11.4.7. SomaLogic, Inc.
     11.4.8.

Segments Covered in the Report

The global aptamers market has been segmented on the basis of

Types

  • Peptide
  • Nucleic Acid

Applications

  • Diagnostics
  • Therapeutics
  • Research & Development
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Eli Lilly & Co.
  • Aptamer Group
  • Merck & Co., Inc.
  • Aptamer Sciences, Inc.
  • Ophthotech Corp.
  • Base Pair Biotechnologies, Inc.
  • SomaLogic, Inc.
  • NOXXON Pharma

Key players competing in the global aptamers market are Eli Lilly & Co.; Aptamer Group; Merck & Co., Inc.; Aptamer Sciences, Inc.; Ophthotech Corp.; Base Pair Biotechnologies, Inc.; SomaLogic, Inc.; and NOXXON Pharma. Many of these players have adopted business strategies such as the launch of new products, the advancement of technologies, mergers, partnerships, and production capacity expansion to increase their market position and expand their consumer base globally. Many of these companies are meticulously engaged in research & development activities to come up with aptamers that can be used for a wide range of medical applications.

Aptamers Market keyplayers

Buy Report